About The Medical Condition EN-1639A
Find the definition of the medical term EN-1639A. EN-1639A defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
EN-1639A
| EN-1639A Medical Condition |
|---|
What's The Definition Of The Medical Condition EN-1639A?
Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Fetal Viabilities ‐ The potential of the fetus-in-utero to survive…
- Immunomagnetic Cell Separations ‐ A cell-separation technique where magnetizable microspheres or…
- Enprostil, (1R-(1(R*),2beta(1E,3R*),3alpha)-Isomer ‐ A synthetic PGE2 analog that has an inhibitory effect on gastric…
- Ethinyl Estradiol, (8 alpha)-Isomer ‐ A semisynthetic estrogen with high oral estrogenic potency. It…
- Congenital Erythropoietic Porphyria ‐ Autosomal recessive porphyria characterized by splenomegaly,…
- Nemaline Myopathy, Childhood Onset ‐ A group of inherited congenital myopathic conditions characterized…
- Cyst, Breast ‐ A chronic disorder comprising three variants which range from…
- Pleasure-Pain Principle ‐ The psychoanalytic concept that man instinctively seeks to avoid…
- Noises, Transportation ‐ Noise associated with transportation, particularly aircraft and…
- Leukemia, Granulocytic ‐ Form of leukemia characterized by an uncontrolled proliferation…